Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
Sign in
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Sign in
Mogrify to present preclini...
MetaVia shows uric acid red...
Annovis secures patent for ...
Eisai, Linus Health launch ...
Alzheon launches second Pha...
Mogrify to present preclini...
MetaVia shows uric acid red...
Annovis secures patent for ...
Eisai, Linus Health launch ...
Alzheon launches second Pha...
Greg Bailey
Economy
Investment
Investment
Global investment leaders weigh in on the future of healthspan
Features
Videos
‘We’re at the longevity inflection point – and the explosion is coming.’
Investment
Juvenescence appoints Dr Richard Marshall CBE as CEO
Investment
Videos
From biotech to inflection points with James Peyer and Greg Bailey
Agetech
Biotech
Development
Drugs
Features
Innovation
Investment
Organ Growth
Senescence
Senolytic drugs
Wellness
Juvenescence (1): from strength to strength in R&D and investment firepower
Google
Microsoft
Apple
LinkedIn
or use your email
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report